Drug Shortage Report for FLUDARABINE PHOSPHATE FOR INJECTION
Report ID | 58634 |
Drug Identification Number | 02283859 |
Brand name | FLUDARABINE PHOSPHATE FOR INJECTION |
Common or Proper name | FLUDARABINE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FLUDARABINE PHOSPHATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 2ML |
ATC code | L01BB |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-08-20 |
Estimated end date | 2018-10-29 |
Actual end date | 2018-10-30 |
Shortage status | Resolved |
Updated date | 2018-11-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-08-21 | English | Compare |
v2 | 2018-08-21 | French | Compare |
v3 | 2018-10-10 | English | Compare |
v4 | 2018-10-10 | French | Compare |
v5 | 2018-11-08 | English | Compare |
v6 | 2018-11-08 | French | Compare |
Showing 1 to 6 of 6